President Donald Trump recently signed an executive order meant to encourage the reshoring of pharmaceutical manufacturing to the U.S. The executive order, signed Aug. 6, includes “buy American” provisions for U.S. government agencies’ procurement of essential medicines and reduces regulatory provisions. The Secretary of Health and Human Services and FDA commissioner, consistent with applicable law,…
Hologic spending more than $50M to expand COVID-19 test production
Hologic (NSDQ:HOLX) is spending $50 million — including $14 million during its most recent quarter — to boost its production of COVID-19 tests. The U.S. government is providing $7.6 million to support the effort. Hologic’s business partner Stratec is also doubling the production of the Panther instruments that run Hologic assays. Get the full story on our sister site…
Pfizer to make Gilead’s remdesivir COVID-19 treatment
Pfizer (NYSE:PFE) announced today that it entered into a multi-year agreement with Gilead Sciences (NSDQ:GILD) to manufacture and supply its antiviral remdesivir treatment. The investigational antiviral remdesivir will be manufactured by Pfizer under the agreement as the company becomes one of the multiple external manufacturing organizations supporting efforts to scale up the supply of the investigational…
U.S. to spend $1B for doses of J&J’s COVID-19 vaccine candidate
The U.S. Dept. of Health and Human Services and Defense Dept. agreed to a $1 billion deal for a vaccine candidate from Johnson & Johnson (NYSE:JNJ). HHS and DoD announced the agreement with Janssen Pharmaceutical, as the J&J subsidiary is set to offer large-scale manufacturing and the delivery of its COVID-19 vaccine candidate, with the federal…
Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK
Sanofi (NYSE:SNY) and GlaxoSmithKline (NYSE:GSK) announced that they reached an agreement with the UK government to supply up to 60 million doses of a COVID-19 vaccine. Subject to a final contract, the UK government will receive the doses of a vaccine candidate developed by the two companies in partnership and based on the recombinant protein-based technology Sanofi used to…
GSK, Sanofi land $2.1B from feds to develop COVID-19 vaccine
The Trump administration has awarded Sanofi (NYSE:SNY) and GlaxoSmithKline (NYSE:GSK) a contract for up to $1.2 billion to develop, manufacture and deliver a vaccine for COVID-19, the companies announced today. The vaccine candidate is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s established pandemic adjuvant (immunity-boosting) technology. Manufacturing will…
Fujifilm Diosynth lands $265m to produce COVID-19 vaccine
Fujifilm Diosynth Biotechnologies announced that its College Station, Texas, site will manufacture a COVID-19 vaccine candidate under a $265 million federal contract. The contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies said it received the federal task order through the Texas A&M System Center for Innovation in Advanced Development &…
SP Industries announces partnership with Ecodyst
Fill-finish drug manufacturing solutions developer SP Industries announced that it entered into a partnership agreement with evaporator developer Ecodyst. Apex, N.C.-based Ecodyst offers a full range of single-sample evaporators with self-cooling condenser technology. The distribution partnership aims to utilize the Ecodyst products to complement Warminster, Pa.-based SP Industries’ SP Genevac with parallel centrifugal evaporators to…
Teknova announces new CEO
Cell culture media, protein purification and molecular biology reagent manufacturer Teknova announced that it appointed Stephen Gunstream as its new CEO. Gunstream has nearly 20 years of experience in life sciences, having previously served as VP and GM for the research and clinical business at BD Biosciences, as well as the CCO at Integrated DNA…
WMFTG announces the launch of its new Certa Plus pump series
Watson-Marlow Fluid Technology Group (WMFTG) announced that it launched its Certa Plus pump series for versatile fluid management in pharmaceuticals. Certa Plus uses the company’s MasoSine sinusoidal pumping technology to function across a range of applications with lower shear, lower power consumption, full traceability and cleanability when transferring syrups, oils, creams and gels, according to…